Dr. Valerie M. Panzarino, MD

Dr. Panzarino practices at University Medical Service Association Inc in Tampa, Florida.

Dr. Panzarino's NPI, 1538179858, was assigned on August 9, 2006. Dr. Panzarino graduated from USF Health Morsani College of Medicine in 1990. Dr. Panzarino holds Florida license ME94165.

Dr. Panzarino's primary practice is University Medical Service Association Inc, at 13101 Bruce B Downs Blvd, Tampa, FL 33612 in Hillsborough County. The practice phone is (813) 821-8038.

Dr. Panzarino's primary practice is University Medical Service Association Inc in Tampa, Florida. Dr. Panzarino is also affiliated with Tampa General Hospital. The medical group on file is USF Therapy Services. Dmand AI also links Dr. Panzarino to 1 more hospital, 1 dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Panzarino practices, 4 sites in all. Vendor and product names are available with a free account.

Pediatrics is Dr. Panzarino's primary specialty in the NPI Registry, under taxonomy code 208000000X. Dr. Panzarino is board certified in pediatric nephrology by the American Board of Pediatrics. Dmand AI has Dr. Panzarino's licenses on file in 4 states: Florida, South Carolina, Georgia and Minnesota.

CMS data shows 14 Medicare services from Dr. Panzarino across 1 procedure code in 2024, for 20 Medicare patients. Medicare paid $1,430 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 20 Medicare patients who saw Dr. Panzarino in 2024. The largest group is under 65, with 20 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. Their average risk score is 7.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Panzarino's median patient age at 14, with 41% women.

In 2024, Dr. Panzarino wrote 278 Medicare Part D claims for 24 patients. 94% of them were for generic drugs. CMS names the drug for 184 of them, across 7 drugs with 11 or more claims each, at $18,254 in total drug cost. In 2023, CMS named 73 claims across 5 drugs.

Dr. Panzarino accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 14 papers to Dr. Panzarino, published from 2004 to 2023. 2023 was the busiest year, with 2. The most frequent topics are Kidney, Anemia and Anti-Bacterial Agents. Dr. Panzarino has published most often in Adv Pediatr. Dr. Panzarino's most frequent co-authors are Clifford E. Kashtan, MD, Steven Roy Alexander, MD and Michelle A. Baum, MD.

Dmand AI links Dr. Panzarino to 1 clinical trial. Conditions studied include Acidosis, Renal Tubular and Renal Tubular Transport, Inborn Errors.

CMS Open Payments shows 4 general payments to Dr. Panzarino from 4 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Nuwellis, Inc. paid the most, $152.

Dmand AI lists 1 award for Dr. Panzarino, most recently Regional Top Doctor in 2014.

Dr. Panzarino graduated from USF Health Morsani College of Medicine in 1990.

Dr. Panzarino is in network with 15 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.